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Clean Needles and Bad Blood:
Needle Exchange as Morality Policy
ELIZABETH A. BOWEN
University of Illinois at Chicago
Jane Addams College of Social Work
The morality policyframework is a lens for understanding the unique
characteristics of policies that attempt to regulate personal morals
and behaviors. Needle exchange, a controversial intervention for
reducing the transmission of HIV in injection drug users, shares
many of the hallmark characteristics of morality policies. Analyz-
ing needle exchange from a morality policy perspective, focusing
on the 21-year ban on federal fundingfor needle exchange, reveals
how value-based arguments have been used in the needle exchange
debate and explains why the issue is likely to remain controversial in
the United States. This analysis adds to the understanding of moral
and political aspects of U.S. HIV/AIDS prevention and care policies.
Key words: HIV prevention, injection drug use, morality policy,
needle exchange
Injection drug use is one of the main HIV transmission
routes in the United States, contributing directly or indirectly
to more than a third of new HIV infections since the beginning
of the epidemic. It has been a key factor in the rising HIV preva-
lence in women, with 58% of HIV positive women contracting
the disease through injection drug use or sexual intercourse
with drug users (Centers for Disease Control and Prevention,
2005). Early in the epidemic, needle exchange emerged as a
solution for reducing the spread of AIDS and other diseases in
injection drug users, based on the simple concept of providing
participants with free, clean needles to use for every injection.
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Needle exchange quickly became key in the HIV prevention
strategies of several European countries, Canada, Australia,
and New Zealand, and the first legal and comprehensive
needle exchange in the United States opened in Tacoma,
Washington in 1988 (Gay Men's Health Crisis, 2009). The effec-
tiveness of needle exchange has been studied extensively, with
meta-analyses such as Cross, Saunders, and Bartelli (1998) and
Ksobiech (2003) indicating that needle exchange effectively
reduces needle sharing and other HIV risk behaviors.
Despite international acceptance of the needle exchange
model and its well-documented efficacy, needle exchange
remains controversial in the United States. In 1988, the same
year the Tacoma needle exchange opened with financial
support from county government, Congress passed a provi-
sion in the Health Omnibus Programs Extension of 1988 to
prohibit federal funding for needle exchange (Gross, 1989; U.S.
General Accounting Office, 1993). The ban remained intact
until 2009. All the while, needle exchange programs-support-
ed by private, state, and local funding-proliferated across the
United States, and a considerable body of research developed,
examining and documenting their effectiveness.
A rational model of policymaking does not explain the
federal government's inaction on needle exchange policy.
Meier (1994) has argued that on the whole, U.S. drug policy is
irrational, and needle exchange is no exception. It is a charged
issue, largely driven by values and morals, instead of logic,
economics, or principles of public health. Morality policy anal-
ysis is an alternative model for understanding policy issues
such as needle exchange, which are not rooted in a rational,
problem-solving approach. In order to understand the evolu-
tion of the issue in federal policy and predict its further de-
velopment, this article provides an overview of the morality
policy framework and applies it to needle exchange, with a
focus on the federal funding ban.
Morality Policy: A Framework for Analysis
The morality policy framework is a lens that can be used
to gain insight into the creation, implementation, and effects of
policies that attempt to regulate personal and moral behavior.
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The framework assumes that there are distinctive aspects of
morality policies and the politics that drive them, which differ
significantly from more economically based policies (Mooney
& Schuldt, 2008). Though analysis of the role of values in poli-
cymaking dates back much earlier (for example, Gusfield,
1963), the morality policy framework has roots in Gormley's
(1986) seminal work on regulatory politics. The definition of
morality policies in Gormley's conceptualization hinges on
two key concepts: salience and complexity.
Defining Morality Policies: Salience and Complexity
Gormley's (1986) analysis is based on the classification
of policy issues on the basis of their salience and complexity.
Issues that are highly salient affect, or are perceived as affect-
ing, a wide range of people in some meaningful way. Typical
salient issues include policies relating to health, the environ-
ment, and public safety. Highly complex issues and policies
are those that require technical expertise to understand and
implement, such as transportation regulation. Based on their
level of salience and complexity, Gormley placed policy issues
into one of four typologies and subsequently generalized
about their characteristics. Figure 1 shows Gormley's salience-
complexity matrix, including some of his issue examples in
each of the four typologies.
Using Gormley's (1986) matrix, needle exchange can be
understood as an issue of high salience and low complexity.
Needle exchange is salient because it addresses two extremely
visible and provocative social problems: drug use and HIV/
AIDS. Illicit drug use is widely prevalent in the United States;
the U.S. Department of Health and Human Services estimates
that there are approximately 21.8 million current illicit drug
users over the age of 12 (Substance Abuse and Mental Health
Services Administration, 2010). Thus, a sizeable portion of
the population has been personally affected by drug use.
Furthermore, the treatment, control, and criminality of drug
use have remained controversial and well-publicized issues in
the United States for decades.
HIV/AIDS is also a highly salient social problem. Despite
ongoing prevention efforts and the investment of billions of
dollars, the continuing spread of HIV/AIDS in the United
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States and countries around the globe means that the issue
is never far from the public's attention. However, HTV/AIDS
differs from many other public health concerns in that it is
so closely associated with two behaviors deemed by many
groups and cultures to be immoral: sex between men, and in-
jection drug use (Fernando, 1993). By addressing HIV/AIDS
risk due to injection drug use, needle exchange is situated at
the intersection of two of the most publicized, highly salient





Figure 1. Examples of policy issues in the salience-complexity
matrix. Morality policies constitute the shaded upper left
quadrangle of high salience and low complexity. Adapted with
permission from "Regulatory issue networks in a federal system,"
by W. T. Gormley, 1986, Polity, 18(4), p. 600.
In terms of complexity, needle exchange can be regarded
as a low complexity issue because of the simplicity of its strat-
egy and objectives. AIDS and other diseases are spread when
injection drug users share needles. Needle exchange seeks to
reduce this by offering drug users new, clean needles for free
or at a very low cost. Most needle exchanges also offer other
services, such as referrals to medical care and drug treatment,
and often serve as a first point of contact for engaging drug
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users in a range of services (Des Jarlais, McKnight, Goldblatt,
& Purchase, 2009). However, the debate about needle exchange
rarely addresses these secondary aspects of exchange pro-
grams. The crux of needle exchange is providing drug users
with free clean needles, a simple concept around which the
needle exchange debate has centered.
Characteristics and Applications of the Morality Policy Framework
In Gormley's (1986) typology issues such as needle ex-
change that are of high salience and low complexity, are clas-
sified under a category titled "hearing room politics" (p. 607).
This designation has implications for how such policies are
debated and implemented, as well as for which members of
the policy community have a role in this process. A diverse
range of policy players, including journalists, politicians,
and citizen activists, is drawn to these issues, which are per-
ceived as important, controversial, and readily understood by
the general public. In hearing room politics, important deci-
sions are usually made through legislation, rather than settled
through the courts or determined by bureaucrats involved in
policy implementation and regulation. In debates about such
issues, the role of experts and scientific data is diminished and
a greater emphasis on values and emotions emerges, prompt-
ing Gormley to conclude, "in fact one sees an amazing amount
of mudslinging, vilification and hyperbole in this issue area"
(p. 617).
Researchers and policy analysts have since refined these
concepts. Meier (1994) referred to the highly salient, low com-
plexity issues in the hearing room politics typology as morality
policies or "the politics of sin" (p. 247). The terms "morality
policies" and "morality politics" were further popularized by
Mooney, who has published extensively on various aspects and
applications of the subject (see Mooney & Lee, 1995; Mooney,
1999, 2001; Mooney & Schuldt, 2008). Mooney's 2001 edited
volume The Public Clash of Private Values explored nuanced
aspects of morality policy analysis, such as the temporal diffu-
sion of morality policies across the states and the role of com-
promise in morality policy implementation.
Morality policy analysis has been used with a diverse
range of issues, from abortion (Patton, 2007) to the death
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penalty (Mooney & Lee, 1999) to public funding for the arts
(Lewis, 2006). The prevention and treatment of HIV/AIDS,
characterized by moral as well as medical elements since the
start of the epidemic, is clearly appropriate for study through
a morality policy lens. One aspect of HIV prevention that has
garnered considerable attention from morality policy analysts
is the debate over abstinence-only versus comprehensive sex
education in schools (Arsneault, 2001; Doan & Williams, 2008;
Vergari, 2001).
In her historical analysis of the politics of abstinence-only
sex education, Arsneault (2001) identifies four characteristics of
morality policies. Arsneault's framework synthesizes the work
of Tatalovich and Daynes (1998), Mooney (2001), and others,
providing a structure that can be readily applied to other
policy areas. The four key characteristics of morality policies
as outlined by Arsneault are: (a) controversy and an inability
to arrive at solutions by looking at empirical data alone; (b)
legislation that is symbolic in nature, rather than instrumental
or focused on concrete policy outcomes; (c) the involvement of
diverse sectors of the policy community, including legislators,
the media, bureaucrats, and citizens; and (d) ongoing debate
surrounding the issue, even after legislation has passed. This
framework can be used to analyze needle exchange policy,
supplementing previous analyses to yield a richer understand-
ing of the political and moral aspects of HIV prevention policy
in the United States.
Analysis: Needle Exchange as Morality Policy
The ban on federal funding for needle exchange endured
from 1988 to 2009, touching five presidential administrations
and withstanding countless changes in congressional compo-
sition and leadership. The ban also surmounted an escalating
body of research demonstrating that participation in needle
exchange reduced HIV transmission and did not increase drug
use-the perpetual main objection of needle exchange oppo-
nents. An analysis of needle exchange as a morality policy
helps to explain the intractability of the federal funding ban
over 21 years. Using Arsneault's (2001) four characteristics of
morality policies, this analysis describes the history of needle
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exchange policy in the United States, focusing on the develop-
ment and durability of the federal funding ban. In addition,
analysis of the four characteristics points to predictions for the
future of needle exchange, following the lifting of the federal
ban in December 2009.
While this analysis incorporates the perspectives of pro-
ponents and opponents of needle exchange, it is reflective of
the author's position in support of needle exchange. Like most
proponents, I take the view that considerable research evidence
substantiates needle exchange as an effective HIV prevention
strategy (U.S. Department of Health and Human Services,
2011). Accordingly, this analysis highlights instances in which
value-based arguments have conflicted with evidence-based
ones, and promotes the role of research in policy making.
Furthermore, this analysis takes a high-level perspective by fo-
cusing on legislative decision-making at the federal level, with
limited attention to the role that grassroots and community
politics have played in the debate. The latter is discussed as an
important area for further research and analysis.
The Contrasting Roles of Values and Evidence
The first characteristic of morality policies in Arsneault's
(2001) framework is that they are marked by controversy; in
debates about morality policies, rigorous research and scien-
tific evidence are deemphasized in favor of value-based argu-
ments. This characteristic is evident in the history of needle
exchange policy in the United States. In 1987, facing the esca-
lating spread of AIDS in injection drug users and their sexual
partners, the National Institute on Drug Abuse (NIDA) con-
vened national and international experts to address needle
sharing. NIDA promptly issued a research monograph with
the findings of the convention (Battjes & Pickens, 1988). The
monograph contains several studies documenting needle-
sharing behaviors among drug users in different parts of the
United States as well as the impact of newly implemented
needle exchange programs in Europe. In their conclusion, the
report editors offer tentative support for needle exchange,
noting that lack of access to clean needles, due to cost and
state drug paraphernalia laws, was a prime factor in needle
sharing, and stating that needle exchange was a promising HIV
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prevention approach that needed to be further studied in the
United States (Battjes & Pickens, 1988).
The first comprehensive AIDS funding legislation, passed
in 1988, similarly echoed a need for further research about
needle exchange, while also establishing needle exchange as
a politically controversial issue. Responding to a more conser-
vative amendment offered by Senator Jesse Helms (R-NC) to
unqualifiedly prohibit federal funding for needle exchange,
Senators Edward Kennedy (D-MA) and Orrin Hatch (R-UT)
offered a less restrictive amendment to the legislation, stipulat-
ing a ban on federal funding until research could demonstrate
that needle exchange would reduce drug use and HIV trans-
mission in the United States (Molotsky, 1988). The amendment
passed and this language was maintained in the 1988 Health
Omnibus Programs Extension, which ultimately incorporated
the AIDS funding legislation.
Such research was quickly forthcoming. Responding to
a request by the House of Representatives Select Committee
on Narcotics Abuse and Control, in 1993 the U.S. General
Accounting Office (GAO) issued a report examining the safety
and efficacy of needle exchange (GAO, 1993). The report,
which reviewed studies of needle exchange programs in the
United States, Europe, Australia, and Canada, contains several
findings in support of needle exchange. Acknowledging
policy makers' concern that needle exchange could increase
drug use, the report states unambiguously that all of the re-
viewed studies meeting evaluation criteria demonstrated no
increase in drug use among needle exchange attendees, and
one study documented that drug users injected less often after
they started participating in a needle exchange program. The
GAO report also confirmed the credibility of a model devel-
oped by Yale University researchers (Kaplan & Heimer, 1992)
that predicted a 33% reduction in new HIV infections over the
course of a year for needle exchange participants.
While proponents have long referenced the GAO report
and subsequent studies as supporting needle exchange, this
body of research has not been without controversy and ambi-
guities. Schechter's (2002) account of his personal involvement
in needle exchange research and policy development offers
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insight into one well-known research-related controversy. In
1997, Schechter and his colleagues published a report evalu-
ating the effectiveness of a Vancouver needle exchange, the
largest in North America (Strathdee et al., 1997). One of the
study's many findings became particularly widely publicized:
Frequent attendees of the needle exchange program had an HIV
prevalence rate of 32%, versus 14% for less frequent attendees.
Schechter describes how several conservative American legis-
lators concluded from this that needle exchange participation
increased HIV transmission and drug use. Schechter and his
colleagues uncovered evidence for an alternate explanation:
that the frequent attendees exhibited more risk behaviors (such
as involvement in prostitution or injecting with other users in
shooting galleries) than the less frequent attendees, resulting
in higher HIV prevalence. They attempted to explain this di-
rectly to legislators as well as to the general public in a New
York Times editorial (Bruneau & Schechter, 1998). Nonetheless,
facing opposition by conservative legislators emboldened by
their interpretation of the Vancouver findings, the Clinton ad-
ministration announced on April 20, 1998 that it would contin-
ue the ban on federal needle exchange funding. This account
demonstrates some of the varying ways in which research
evidence can be used and interpreted in value-charged policy
debates.
The Symbolic Nature of Morality Policy Legislation
A related characteristic of morality policies is that their
legislation often has symbolic rather than instrumental goals.
Such legislation typically does not carry meaningful budget
implications; in fact, morality policy legislation is sometimes
used by politicians to distract from divisive budgetary debates
(Meier, 1994). An example of symbolically-rooted needle ex-
change policy can be found in a spate of proposed legislation
following President Bill Clinton's decision to uphold the needle
exchange federal funding ban in 1998. Prompted by this close
call, conservative legislators in the House and Senate rushed to
introduce new legislation to permanently ban federal funding
for needle exchange. The push for legislation was symbolic in
itself, since Clinton had just announced that he would retain
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the ban. The proposed legislation was little more than a per-
petuation of the status quo. The goals of the legislation were
also symbolic, focused on the removal of a controversial in-
tervention from the policy menu of options, rather than offer-
ing alternate solutions to reducing HIV and other infections in
drug users.
The debate in the House over H.R. 409, the proposed leg-
islation to permanently prohibit federal funding for needle
exchange, is rich in examples of emblematic language from
both its proponents and opponents. At the start of the debate,
Representative Gerald B. H. Solomon (R-NY) tied the issue to
a topic that often raises emotions and concerns about moral-
ity: children and youth. In his introduction to the legislation,
Solomon stated that the proposed bill "affects every child in
this country and every future child in the next generations
to come" and went on to say that "the Clinton administra-
tion's endorsement of needle exchange programs is part of
an intolerable message to our Nation's children sent by the
White House that drug use is a way of life" (Solomon, 1998, p.
H2445). Shifting the debate from injection drug users, the pop-
ulation targeted by needle exchange, to the speculated effects
of needle exchange on children and youth is indicative of the
symbolic rather than instrumental nature of the legislation.
Solomon also focused on the urgency of the matter. Referring
not to the lives of drug users lost to HIV but to the risk of youth
becoming addicted to drugs due to needle exchange normal-
izing drug use, he stated that "what is even more important
is that the bill must be on the floor today because tomorrow
another life might be lost" (Solomon, 1998, p. H2447).
In the debate, proponents of needle exchange referenced
the scientific evidence in support of needle exchange and the
high cost of treating AIDS, but also made symbolic arguments.
Representative Nancy Pelosi (D-CA) cited statistics indicating
that the majority of HTV infections in women of childbearing
age were due of injection drug use or sex with drug users, and
stated that "when we fail to fund needle exchange, we are fore-
going a proven intervention that can save the lives of women
and children" (Pelosi, 1998, p. H2454). This may have been a
response to Solomon's focusing of the debate on the issue of
youth drug abuse, and again shifts focus from the target of the
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intervention-injection drug users, most of whom are male-
to a comparably innocent population of their female partners
and children. As Dr. Elizabeth Pisani, an AIDS epidemiologist
and former journalist, writes, such an argument has often been
used to advocate for funding for needle exchange, condoms,
and other HIV prevention measures:
HIV prevention is relatively cheap. For the price
of a condom or a sterile needle today, you can save
yourself several thousand dollars in health systems
costs caring for an AIDS patient ten years from now...
[but] the money argument often isn't enough to make
politicians do nice things for junkies. How about the
babies argument then? Politicians are always happy to
do nice things for innocent women and babies. (Pisani,
2008, p. 27)
Activists, Researchers, and Politicians: Policy Community Roles
The third characteristic of morality policies is that they
attract diverse sectors of the policy community. Politicians
make it a point to maintain a position on morality policy
issues, particularly during campaigns; citizen groups advo-
cate various positions; researchers and academics contribute
their findings on the subject; and journalists cover all of this
action extensively. In its nearly 25-year history, needle ex-
change has proved to be no exception, with a variety of policy
actors seeking different forms of influence and involvement
in the issue. Along with the media, which has covered the
needle exchange debate since near its inception (e.g., Marriott,
1988; Altman, 1989), community activists, researchers, and
politicians have all played unique roles in the development of
needle exchange policy and programs.
Community organizations and AIDS advocacy groups
have been critical in the establishment and growth of needle
exchange programs. Early in the AIDS epidemic, when needle
exchange was illegal in many areas due to state and local drug
paraphernalia laws, community groups pushed the policy
forward by illegally operating small needle exchange pro-
grams. Two examples are the Bronx-Harlem Needle Exchange
Program and the Lower East Side Needle Exchange Program,
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which distributed needles to drug users illegally for two
years before becoming partners in New York City's first legal
needle exchange in 1992 (Hevesi, 1992). In addition to directly
running programs, national organizations such as AIDS Action
and the Harm Reduction Coalition, as well as many local or-
ganizations, directly challenged the ban on federal funding
and advocated to change state and local drug paraphernalia
laws to promote needle access. For example, Moseley, Melton,
and Francisco (2008) describe a state-level advocacy effort by
the North Carolina Harm Reduction Coalition to secure state
funding and legal permission for the two needle exchanges
operating in the state. In the absence of federal funding or a
national strategy on needle exchange, such efforts were critical
in the diffusion of needle exchanges across states and regions.
Community organizations have also mobilized to oppose
needle exchange. Religious groups, clergy, and neighborhood
business associations have historically spoken out against
needle exchange in some communities (Tempalski et al., 2007).
For example, at the start of the needle exchange debate, many
African American churches and other groups opposed needle
exchange. Such groups articulated that needle exchange was at
best a misguided effort that would not address the roots of ad-
diction, and at worst, was a risky and potentially devastating
experiment that could increase drug use, already rampant in
many African American urban communities in the late 1980s
(Marriott, 1988). These concerns must be considered in light of
the history of deceptive and racist scientific experimentation in
African American communities, exemplified by the Tuskegee
syphilis study (Thomas & Quinn, 1993). Over time, as the dis-
proportionate prevalence of HIV in African Americans became
clear and evidence grew in support of needle exchange,
many groups changed course. On National Black HTV/AIDS
Awareness Day in 2008, the NAACP, National Urban League,
and other black advocacy groups issued a statement in support
of needle exchange and asked Congress to overturn the federal
funding ban (Crary, 2008).
Researchers and academics have also involved themselves
in the development of needle exchange policy. Since one of
the characteristics of morality policy is an emphasis on values
over facts, the role of experts and professionals in policymak-
ing tends to be diminished (Arsneault, 2001; Mooney, 2001).
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Nonetheless, academics and medical professionals have staked
a position in the needle exchange debate, primarily as propo-
nents but occasionally as opponents to the policy.
A prime example of academic advocacy for needle ex-
change can be found in Schechter (2002). A physician and pro-
fessor at the University of British Columbia, Schechter became
embroiled in public controversy when the results of his team's
study of a large Vancouver needle exchange program indicated
that frequent attendees of the program had higher HIV preva-
lence than less frequent attendees, as described above. The situ-
ation culminated in Schechter meeting in Vancouver with rep-
resentatives of the U.S. Office of National Drug Control Policy
to explain that the study results did not indicate that needle
exchange attendance increased HIV prevalence. In addition
to advocacy efforts by individual researchers, professional
organizations, including the American Medical Association
and American Public Health Association, came out in support
of needle exchange (Svalavitz, 2009), lending credence to the
demands of grassroots activists. Though less common, there
are also instances of academics and health professionals speak-
ing out against needle exchange, such as psychiatrist Dr. James
L. Curtis, an outspoken critic who authored a New York Times
editorial on the topic (Curtis, 1998).
Politicians are key players in morality policy development.
Since morality policies are low-complexity issues, they provide
politicians with the opportunity to take a decisive stance on
matters that are both salient and understandable to the voting
public, and often widely covered by the media. Meier (1994) es-
tablishes that drug-related morality policies in particular "are
good politics" since "drug abuse is a universal bad" (p. 251).
Therefore, while politicians are generally attracted to moral-
ity policies, for issues such as needle exchange-both a drug-
related policy and a public health intervention-politicians are
wary of adopting a stance that may make them appear soft on
crime or encouraging of drug addiction.
This issue emerged during the 2008 Democratic presiden-
tial primaries. Candidate Barack Obama stated he would over-
turn the ban on federal funding, while his opponent Hillary
Clinton, perhaps more aware of the political circumstances
surrounding her husband's decision not to overturn the ban
in 1998, gave an ambivalent response regarding her stance on
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needle exchange (Svalavitz, 2009). But in spite of his campaign
promises, and much to the consternation of advocates, Obama's
initial 2010 budget proposal retained the funding ban. In addi-
tion to the fear of appearing soft on crime, politicians are aware
that injection drug use is an issue that lacks a strong lobby or
an empowered electoral base. For injection drug and other
issues such as homelessness, there is typically little promise
of personal gain to prompt politicians' support (Arnold, 1989).
Nonetheless, politicians have taken a stand on both sides of
the issue, as is evidenced by the 1998 Congressional debates
described above, and by the Obama administration's eventual
overturning of the ban and inclusion of needle exchange in the
National HIV/AIDS Strategy (White House Office of National
AIDS Policy, 2010).
Enduring Controversy and Debate
The final characteristic of morality policies is that they
remain controversial; even the passage of important legislation
does not end the debate (Arsneault, 2001). For needle exchange,
the key legislation is the 2010 Consolidated Appropriations Act,
passed in December 2009, which overturned the 21-year ban
on federal funding for needle exchange. Despite a Democratic
Congress and a president who offered at least tentative
support to needle exchange, the repeal of the ban was not a
foregone conclusion. After the ban was left intact in Obama's
initial budget proposal, the House narrowly voted to eliminate
it in July 2009 (Egelko, 2009). At this point, the bill contained
a Republican-sponsored amendment that would have prohib-
ited funding for programs located within 1,000 feet of schools,
day care centers, playgrounds, parks, and youth centers-es-
sentially eliminating all viable needle exchange sites in urban
areas. The amendment was removed by a House-Senate com-
mittee before the final bill was passed.
Even with the lifting of the ban, the fate of appropriations
for needle exchange remains uncertain. In July 2010, the White
House Office of National AIDS Policy released the National
HIV/AIDS Strategy, which endorsed needle exchange as a
prevention approach on the grounds that "several studies have
found that providing sterilized equipment to injection drug
users substantially reduces risk of HIV infection ... and does
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not increase drug use" (pp. 16-17). Coupled with the overturn-
ing of the funding ban, this represents a significant shift at
the executive level from the ambivalence of previous admin-
istrations toward needle exchange. While as of April 2011 no
federal money had yet been allocated specifically for needle
exchange, Department of Health and Human Services grant-
ees were permitted to use remaining FY 2010 HIV prevention
funds for needle exchange, following departmental guidelines
released in July 2010 (U. S. Department of Health and Human
Services, 2010). In March 2011 the Surgeon General endorsed
needle exchange, a necessary prerequisite for enabling states
to use Substance Abuse Prevention and Treatment block grant
funds for needle exchange programs (Knopf, 2011).
Despite these landmark policy events, needle exchange, its
funding, and its legality in jurisdictions where strict drug para-
phernalia laws still apply are likely to remain controversial. In
the absence of substantial federal funding, state funding and
support remains a critical issue. For example, in New Jersey,
a state with tens of thousands of injection drug users, pilot
needle exchange programs were granted legal status only in
2006, and are still constrained by extremely limited state and
local funding (Mulvihill, 2008). The morality policy framework
informs us that the repeal of the federal funding ban will not
eliminate local concerns or state funding controversies about
needle exchange; furthermore, when, how, and how much
federal money will be allocated to needle exchange remain un-
answered questions.
Discussion
Analysis of needle exchange as a morality policy provides
an explanation for the endurance of the 21-year-long ban on
federal funding for needle exchange. Throughout its span, the
ban was a rallying point for AIDS activists, some of whom
began their own needle exchanges, despite lacking both gov-
ernment funding and legal permission (Fernando, 1993; Gross,
1989). The ban was also a source of consternation for research-
ers and academics who believed that their decades of schol-
arship provided rigorous evidence supporting the safety and
efficacy of needle exchange (Schechter, 2002). Morality policy
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analysis demonstrates that policy issues that can be framed in
moral terms-and in particular, issues related to "sinning,"
such as drug abuse (Meier, 1994)-are not ultimately driven
by the quality of research evidence or the testimony of experts.
Instead, and in contrast to other Western countries that view
drug use in less moralistic terms, the needle exchange debate
in the United States has been marked by value-based argu-
ments, symbolic legislation, and controversy that is likely to
endure well past the 2009 repeal of the federal funding ban.
This analysis focused on one aspect of needle exchange
policy, the ban on federal funding. Further research on needle
exchange should explore other aspects, such as changes in
state and local drug paraphernalia laws that affect the legal-
ity of needle exchange and state funding trends. Mooney and
Lee (2001) suggest that the diffusion of morality policies across
states may differ significantly from the diffusion patterns of
other types of policies. Further analysis should explore the dif-
fusion of needle exchange and the factors contributing to the
spread of needle exchanges from one state in 1988 to 31 states
in 2007 (Des Jarlais et al., 2009). Grassroots and community
politics are key in the development and diffusion of moral-
ity policies, and a more detailed exploration of the roles that
grassroots groups and coalitions have played in supporting
and opposing needle exchanges in different locations also war-
rants further attention.
Additionally, future research should also address aspects
of implementation, since, as Meier (1994) writes, "policy
implementation is the real policy" (p. 247). Though compro-
mise is not typically associated with the polarizing issues that
morality policies address, Vergari (2001) describes the role of
compromise in states' implementation of abstinence-only sex
education policy. Research should determine if elements of
compromise are present in future funding and allocation deci-
sions. The inclusion of needle exchange in the National HIV/
AIDS Strategy also provokes a question: will the federal gov-
ernment issue any challenge to the states and localities where
needle exchange is still illegal due to drug paraphernalia laws?
2011 marked the 30 h anniversary of the Centers for Disease
Control and Prevention's reporting of the first AIDS cases in
the United States. Since the beginning of the epidemic, the
politics underlying the policies that distribute prevention and
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care services to people affected by HIV/AIDs in the United
States and abroad have been the subject of intense analysis and
debate (e.g. Barney et al., 2010). Issues ranging from the cost of
AIDS drugs to the role of harm reduction-based interventions
in HIV prevention have been discussed and debated by politi-
cians and ordinary citizens alike and covered extensively in the
media (Levitt & Rosenthal, 1999). Analyzing needle exchange
from a morality policy perspective yields a better understand-
ing of the role that values and morals have played, alongside
scientific knowledge and budgetary concerns, in this area of
U.S. HIV prevention policy. As policy makers and practitioners
alike enter a new decade in the struggle to effectively prevent
and treat HIV/AIDS, values and morals will likely continue to
play important roles in finding solutions.
Author's Note: After this article was accepted but prior to publica-
tion, the ban on federal funding for needle exchange was reinstated
by Congress, in December 2011. While this recent development is
not included in this analysis, the return of the funding ban after its
elimination in 2009 is consistent with the article's conclusion, that
needle exchange-like all morality policies-is likely to remain con-
troversial and engender many shifts in policy in a context of ongoing
debate.
Acknowledgement: The author wishes to acknowledge Alice K.
Butterfield, PhD, for her comments on an earlier version of this
manuscript.
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